Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients

Autor: Wang, Tianjiao 1, 21, ∗, Navenot, Jean-Marc 1, 21, ∗∗, Rafail, Stavros 2, Kurtis, Cynthia 1, Carroll, Mark 3, Van Kerckhoven, Marian 4, Van Rossom, Sofie 4, Schats, Kelly 4, Avraam, Konstantinos 5, Broad, Robyn 6, Howe, Karen 7, Liddle, Ashley 6, Clayton, Amber 7, Wang, Ruoxi 3, Quinn, Laura 8, Sanderson, Joseph P. 8, McAlpine, Cheryl 6, Carozza, Carly 9, Pimpinella, Eric 9, Hsu, Susan 9, Brophy, Francine 10, Elefant, Erica 10, Bayer, Paige 10, Williams, Dennis 11, Butler, Marcus O. 12, Clarke, Jeffrey M. 13, Gainor, Justin F. 14, Govindan, Ramaswamy 15, Moreno, Victor 16, Johnson, Melissa 17, Tu, Janet 18, Hong, David S. 19, 22, ∗∗∗, Blumenschein, George R., Jr. 20, 22, ∗∗∗∗
Zdroj: In Molecular Therapy - Methods & Clinical Development 13 June 2024 32(2)
Databáze: ScienceDirect